The use of salivary stimulant pastilles to improve compliance in women taking oxybutynin hydrochloride for detrusor instability: A pilot study

British Journal of Urology

Volumn 80, Issue 3, 1997, Pages 414-416

  Hooper, P ^a   Tincello, D G ^a   Richmond, D H ^a  

^a LIVERPOOL WOMEN S HOSPITAL   (United Kingdom)

Author keywords

Compliance; Detrusor instability; Oxybutynin; Side effects; Xerostomia

Indexed keywords

OXYBUTYNIN; SALIVA SUBSTITUTE; SALIVIX; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DETRUSOR DYSSYNERGIA; DISEASE SEVERITY; DRUG EFFICACY; DYSPEPSIA; FEMALE; HUMAN; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; SALIVATION; SYMPTOM; XEROSTOMIA;

EID: 0031402079     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1997.00365.x     Document Type: Article

References (5)

1. Wise BG, Cardozo ID. The urge syndrome. Curr Obstet Gynecol 1992; 2: 105-10
2. Abrams P, Blaivas J, Stanton SL. Standardisation of terminology of lower urinary tract function. Scand J Vrol Nephrol 1988; 114, Suppl: 5-19
3. Yarker YE, Goa KL, Fitton A. Oxybutynin: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability. Drugs Ageing 1995; 6: 243-62
4. Enzelberger H, Helmer H, Kurz C. Intravesical instillation of oxybutynin in women with idiopathic detrusor instability; a randomised trial. Br J Obstet Gynecol 1995; 102: 929-30
5. Moore KM, Hay DM, Imrie AE, Watson A, Goldstein M. Oxybutynin chloride (3 mg) in the treatment of women with idiopathic detrusor instability. BrJUrol 1990; 66: 479-85